Physician Education: Bridging Clinical Research and Patient Care

Faculty Profile

Professor of Medicine
University of Pennsylvania School of Medicine
Philadelphia, PA

Topics of Professional Interest:
  • Antiretroviral therapy
  • Treatment of virologic failure
  • Metabolic complications of antiretroviral therapy
Current Professional Summary:

Dr Tebas is a Professor of Medicine at the University of Pennsylvania School of Medicine and Principal Investigator in the AIDS Clinical Trial Unit at the University of Pennsylvania.

Committees and Organizations:
  • Complications of HIV Disease RAC Viral Diseases Pathogen Study Group, National Institute of Allergy and Infectious Diseases, AIDS Clinical Trial Group (1997–)
  • Complications of HIV Disease RAC Metabolic Study Group, National Institute of Allergy and Infectious Diseases, AIDS Clinical Trial Group (1998–)
Honors and Awards:
  • Premio Extraordinario Fin la carrera (Summa Cum Laude), Universidad Autónoma de Madrid (1986)
  • SmithKline Beecham Junior Faculty Award (2000)
  • Universidad Autónoma de Madrid, Graduate of the School of Medicine and Surgery (1985)
  • Universidad Autónoma de Madrid, Clínica Puerta de Hierro, Residency in Internal Medicine, (1987–1992)
  • Universidad Autonoma de Madrid, MD (1991)
  • Washington University, Fellowship in Infectious Diseases (1992–1996)
Selected Publications:
  1. Tebas P, Niece R, Storch G. Decision analysis about the use of CSF PCR in the diagnosis of herpes simplex encephalitis. Am J Med. 1998;105:287-295.
  2. Havlir DV, Marschner IC, Hirsch MS, Collier AC, Tebas P, Bassett RL, Ioannidis JPA, Holohan MK, Leavitt R, Boone G, Richman DD. Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. N Engl J Med. 1998;339:1261-1268.
  3. Yarasheski KE, Teas P, Sigmund C, et al. Insulin resistance in HIV protease inhibitor-associated diabetes. J Acquir Immune Defic Syndr. 1999;21:209-216.
  4. Tantisiriwat W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ. Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy. Clin Infect Dis. 1999;28:1152-1154.
  5. Powderly WG, Tebas P. Nelfinavir, a new protease inhibitor: early clinical results. AIDS. 1999;13:S41-S48.
  6. Havlir D, Hellmann NS, Petropoulos CJ, Whitcomb JM, Collier AC, Hirsch MS, Tebas P, Sommadossi J-P, Richman DD. Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens. JAMA. 2000;283:229-234.
  7. Squires KE, Gulick R, Tebas P, et al. A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combinaton with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I). AIDS. 2000;14:1591-1600.
  8. Ioannidis JPA, Havlir DV, Tebas P, Hirsch MS, Collier AC, Richman DD. Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication. AIDS. 2000;14:1481-1488.
  9. Tebas P, Patick AK, Kane EM, et al. Virologic responses to a ritonavir-saquinavir-containing regimen in patients who had previously failed nelfinavir. AIDS. 1999;13:F23-F28.
  10. Tebas P, Powderly WG. Claxton S. Marin D. Tantisiriwat W. Teitelbaum SL. Yarasheski KE. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS. 2000;14:F63-F67.